The acquisition of Appili Therapeutics by Aditxt, Inc. is seen as a positive development by the market, leading to an increase in Aditxt's stock price. This strategic acquisition is likely to enhance Aditxt's product portfolio and market reach, contributing to its long-term growth. The positive market reaction is reflected in the stock's upward movement, indicating investor confidence in the potential synergies and growth opportunities arising from this acquisition.